Smith & Nephew Supartz Promotional Claims Draw Scrutiny From FDA, NAD

Smith & Nephew should take steps to ensure that device promotional brochures with claims not intended for U.S. markets are not circulated domestically, according to the National Advertising Division of the Council of Better Business Bureaus

More from Archive

More from Medtech Insight